A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir
Status:
Completed
Trial end date:
2018-04-09
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose
of odalasvir (ODV) in participants with severe renal impairment and compare with the PK in
matched participants with normal renal function.